Glutathione S-Transferase Mu 5 (GSTM5) is an enzyme that belongs to the mu class of the glutathione S-transferase (GST) family. These enzymes play a crucial role in the detoxification of electrophilic compounds, including carcinogens, therapeutic drugs, environmental toxins, and products of oxidative stress, by catalyzing their conjugation with glutathione .
The GSTM5 gene is located on chromosome 1p13.3 and is part of a gene cluster that encodes the mu class of GST enzymes . The gene is highly polymorphic, meaning it has many genetic variations that can influence an individual’s susceptibility to carcinogens and toxins, as well as the toxicity and efficacy of certain drugs . The GSTM5 protein consists of 218 amino acids and has a molecular weight of approximately 25 kDa .
GSTM5 functions by catalyzing the conjugation of reduced glutathione to a wide variety of hydrophobic and electrophilic compounds . This reaction is essential for the detoxification process, as it transforms harmful compounds into more water-soluble forms that can be easily excreted from the body . The enzyme’s activity is crucial in protecting cells from oxidative stress and maintaining cellular homeostasis .
Recombinant human GSTM5 is produced using recombinant DNA technology, where the GSTM5 gene is cloned and expressed in a host organism, typically Escherichia coli . The recombinant enzyme retains its biological activity and is used in various research applications, including studies on detoxification mechanisms, drug metabolism, and the development of therapeutic agents .
Recombinant GSTM5 is widely used in biochemical and pharmacological research. It serves as a model enzyme for studying the detoxification of electrophilic compounds and the role of GSTs in drug metabolism . Additionally, it is used in the development of assays to screen for potential inhibitors or activators of GST activity, which can have therapeutic implications for diseases related to oxidative stress and toxin exposure .